A TYPICAL PATIENT WITH ATRIAL FIBRILLATION AND RENAL DYSFUNCTION - HOW TO PREVENT STROKE?
Aim. To evaluate efficacy and safety of rivaroxaban for stroke and systemicembolism prevention in patients with AF of non-valvular cause and concomitantCKD.Material and methods. Totally 16 patients with AF included, having chronic kidneydisease of II-III stages, who during a year were being assessed...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2015-05-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/333 |